University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Mammograms Bad for Young Women with Breast Cancer Genes?

March 17, 2009

Mammography is widely used to screen for tumors in young women -- even women in their 20s -- who inherit a genetic mutation that confers a very high risk for breast cancer. But new research now suggests that exposing the youngest of these women to ...

UCSF Receives $125 Million for New Medical Center at Mission Bay

March 13, 2009

UCSF has received one of the largest gifts in its 145-year history -- $125 million -- as the lead funding for a state-of-the-art medical center at the Mission Bay campus. The transformative donation injects a shot of adrenaline into an ambitious project that will not ...

Scientists Create Mouse Model of Melanoma that Generates Hope for the Use of Targeted Therapies

March 12, 2009

Researchers have developed a new mouse model that allows them to replicate normal pigment cells at the earliest stages of conversion to malignant skin cancer in humans. After testing the mouse with a combination of two drug therapies, the team found the treatment caused a ...

Chancellor Bishop Witnesses President Obama Ushering in New Era of Scientific Integrity

March 9, 2009

UCSF Chancellor J. Michael Bishop, MD, joined his scientific colleagues on Monday to witness President Barack Obama signing an executive order overturning the Bush administration's restrictions on federal funding of human embryonic stem cell research. UCSF stem cell scientists talked about what the new stem ...

High Blood Pressure Linked to Earlier Death among African-American Breast Cancer Patients

March 4, 2009

A study by researchers at the University of California, San Francisco has shown that hypertension, or high blood pressure, is a predictor of mortality among breast cancer patients, especially those who are African-American, and that hypertension accounts for approximately 30 percent of the survival disparity ...

Study Sheds Light on Angiogenesis Inhibitors, Points to Limitations, Solutions

March 2, 2009

A new generation of cancer drugs designed to starve tumors of their blood supply -- called "angiogenesis inhibitors" -- succeeds at first, but then promotes more invasive cancer growth -- sometimes with a higher incidence of metastases, according to a new study in animals. The ...